Ben Kompa joined Flagship Pioneering in 2022 as an Associate and works on early-stage company creation at the intersection of machine learning and biotechnology. As part of this role, he works within a venture creation team to establish the scientific vision, research and development strategy, intellectual property, and operations of innovative bioplatform companies.
Prior to joining Flagship, Ben completed his PhD in Bioinformatics and Integrative Genomics program at Harvard Medical School. His research in the lab of Dr. Andrew Beam focused on machine learning applications to biomedical problems. This included developing new ways to understand electronic health records, RNA-seq expression data, and causal effects of medical treatments.
Before starting his PhD, Ben interned at Microsoft Research where he developed machine learning models for medical imaging segmentation. His work has been published in Digital Medicine and the proceedings of Neural Information Processing Systems (NeurIPS).
Ben earned a B.S. in Mathematics and B.A. in Computer Science at the University of North Carolina at Chapel Hill, where he was a Colonel Robinson Scholar. He went on to obtain an M.Phil. with Distinction in Computational Biology at the University of Cambridge, where he was a Churchill Scholar.